273 related articles for article (PubMed ID: 32217467)
1. Quantitative sudomotor test helps differentiate transthyretin familial amyloid polyneuropathy from chronic inflammatory demyelinating polyneuropathy.
Fortanier E; Delmont E; Verschueren A; Attarian S
Clin Neurophysiol; 2020 May; 131(5):1129-1133. PubMed ID: 32217467
[TBL] [Abstract][Full Text] [Related]
2. The diagnostic accuracy of Sudoscan in transthyretin familial amyloid polyneuropathy.
Castro J; Miranda B; Castro I; de Carvalho M; Conceição I
Clin Neurophysiol; 2016 May; 127(5):2222-7. PubMed ID: 27072093
[TBL] [Abstract][Full Text] [Related]
3. The value of electrochemical skin conductance measurement using Sudoscan® in the assessment of patients with familial amyloid polyneuropathy.
Lefaucheur JP; Zouari HG; Gorram F; Nordine T; Damy T; Planté-Bordeneuve V
Clin Neurophysiol; 2018 Aug; 129(8):1565-1569. PubMed ID: 29883834
[TBL] [Abstract][Full Text] [Related]
4. Transthyretin amyloid polyneuropathies mimicking a demyelinating polyneuropathy.
Lozeron P; Mariani LL; Dodet P; Beaudonnet G; Théaudin M; Adam C; Arnulf B; Adams D
Neurology; 2018 Jul; 91(2):e143-e152. PubMed ID: 29907605
[TBL] [Abstract][Full Text] [Related]
5. Transthyretin familial amyloid polyneuropathy (TTR-FAP): Parameters for early diagnosis.
Escolano-Lozano F; Barreiros AP; Birklein F; Geber C
Brain Behav; 2018 Jan; 8(1):e00889. PubMed ID: 29568686
[TBL] [Abstract][Full Text] [Related]
6. Assessment of autonomic innervation of the foot in familial amyloid polyneuropathy.
Zouari HG; Ng Wing Tin S; Wahab A; Damy T; Lefaucheur JP
Eur J Neurol; 2019 Jan; 26(1):94-e10. PubMed ID: 30102818
[TBL] [Abstract][Full Text] [Related]
7. Nerve Ultrasound Comparison Between Transthyretin Familial Amyloid Polyneuropathy and Chronic Inflammatory Demyelinating Polyneuropathy.
Du K; Xu K; Cheng S; Lv H; Zhang W; Wang Z; Yuan Y; Meng L
Front Neurol; 2021; 12():632096. PubMed ID: 33716932
[No Abstract] [Full Text] [Related]
8. CIDP variants in diabetes: measuring treatment response with a small nerve fiber test.
Névoret ML; Vinik AI
J Diabetes Complications; 2015 Mar; 29(2):313-7. PubMed ID: 25466645
[TBL] [Abstract][Full Text] [Related]
9. [Transthyretin Familial Amyloid Polyneuropathy - Disease Profile of a Multisystem Disorder].
Niemietz C; Röcken C; Schilling M; Stypmann J; Uhlig CE; Schmidt HH
Dtsch Med Wochenschr; 2018 Mar; 143(6):427-430. PubMed ID: 29544239
[TBL] [Abstract][Full Text] [Related]
10. Genotypic and phenotypic presentation of transthyretin-related familial amyloid polyneuropathy (TTR-FAP) in Turkey.
Durmuş-Tekçe H; Matur Z; Mert Atmaca M; Poda M; Çakar A; Hıdır Ulaş Ü; Oflazer-Serdaroğlu P; Deymeer F; Parman YG
Neuromuscul Disord; 2016 Jul; 26(7):441-6. PubMed ID: 27238058
[TBL] [Abstract][Full Text] [Related]
11. Transthyretin familial amyloid polyneuropathy due to lle107Val mutation mimicking atypical chronic inflammatory demyelinating polyneuropathy: case report.
Gondim FAA; Filha JGH; Jordanova A
Acta Neurol Belg; 2020 Feb; 120(1):201-203. PubMed ID: 30560419
[No Abstract] [Full Text] [Related]
12. "Red-flag" symptom clusters in transthyretin familial amyloid polyneuropathy.
Conceição I; González-Duarte A; Obici L; Schmidt HH; Simoneau D; Ong ML; Amass L
J Peripher Nerv Syst; 2016 Mar; 21(1):5-9. PubMed ID: 26663427
[TBL] [Abstract][Full Text] [Related]
13. Retrospective study of a TTR FAP cohort to modify NIS+7 for therapeutic trials.
Suanprasert N; Berk JL; Benson MD; Dyck PJ; Klein CJ; Gollob JA; Bettencourt BR; Karsten V; Dyck PJ
J Neurol Sci; 2014 Sep; 344(1-2):121-8. PubMed ID: 25012480
[TBL] [Abstract][Full Text] [Related]
14. Variable presentations of TTR-related familial amyloid polyneuropathy in seventeen patients.
Cappellari M; Cavallaro T; Ferrarini M; Cabrini I; Taioli F; Ferrari S; Merlini G; Obici L; Briani C; Fabrizi GM
J Peripher Nerv Syst; 2011 Jun; 16(2):119-29. PubMed ID: 21692911
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic hallmarks and pitfalls in late-onset progressive transthyretin-related amyloid-neuropathy.
Dohrn MF; Röcken C; De Bleecker JL; Martin JJ; Vorgerd M; Van den Bergh PY; Ferbert A; Hinderhofer K; Schröder JM; Weis J; Schulz JB; Claeys KG
J Neurol; 2013 Dec; 260(12):3093-108. PubMed ID: 24101130
[TBL] [Abstract][Full Text] [Related]
16. Single-centre experience on transthyretin familial amyloid polyneuropathy: case series and literature review.
Martens B; De Pauw M; De Bleecker JL
Acta Neurol Belg; 2018 Jun; 118(2):179-185. PubMed ID: 29524093
[TBL] [Abstract][Full Text] [Related]
17. Potential Role of In Vivo Confocal Microscopy for Imaging Corneal Nerves in Transthyretin Familial Amyloid Polyneuropathy.
Rousseau A; Cauquil C; Dupas B; Labbé A; Baudouin C; Barreau E; Théaudin M; Lacroix C; Guiochon-Mantel A; Benmalek A; Labetoulle M; Adams D
JAMA Ophthalmol; 2016 Sep; 134(9):983-9. PubMed ID: 27367055
[TBL] [Abstract][Full Text] [Related]
18. Electrophysiological demyelinating features in hereditary ATTR amyloidosis.
Ohashi N; Kodaira M; Morita H; Sekijima Y
Amyloid; 2019 Mar; 26(1):15-23. PubMed ID: 30688105
[TBL] [Abstract][Full Text] [Related]
19. [Familial amyloid polyneuropathy: clinicopathological aspects].
Koike H; Sobue G
Brain Nerve; 2014 Jul; 66(7):749-62. PubMed ID: 24998820
[TBL] [Abstract][Full Text] [Related]
20. Characterization of Pain in Familial Amyloid Polyneuropathy.
Ng Wing Tin S; Planté-Bordeneuve V; Salhi H; Goujon C; Damy T; Lefaucheur JP
J Pain; 2015 Nov; 16(11):1106-14. PubMed ID: 26291275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
